Clinical Characteristics of Primary Liver Cancer
A Single Center, Retrospective Clinical Study on the Clinical Characteristics of Primary Liver Cancer
1 other identifier
observational
1,000
1 country
1
Brief Summary
Primary liver cancer (PLC) is the sixth most common malignancy in the world and the third most common cause of malignancy death. In 2020, there were about 905,677 new cases of PLC worldwide, and 830,180 deaths. Despite the availability of a variety of treatments for PLC, the 5-year net survival rate is still only 5% to 30%. How to effectively reduce the disease burden of PLC is a major public health problem that needs to be solved worldwide. The clinical characteristics and prognosis of PLC caused by different pathogenic factors are different. Therefore, it is of great significance to fully identify the risk factors of PLC, be familiar with the clinical characteristics and prognosis of disease development, and understand the relevant monitoring and follow-up strategies for the prevention and treatment of PLC.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2010
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2010
CompletedFirst Submitted
Initial submission to the registry
March 15, 2024
CompletedFirst Posted
Study publicly available on registry
March 22, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
August 31, 2024
CompletedMarch 27, 2024
March 1, 2024
14.7 years
March 15, 2024
March 25, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Epidemiological characteristics of overall cohort by liver disease etiology
Epidemiological characteristics of overall cohort by liver disease etiology, including HBV, HCV, NAFLD, ALD and others.
0 year
Clinical characteristics of overall cohort by liver disease etiology
Clinical characteristics of overall cohort by liver disease etiology, including HBV, HCV, NAFLD, ALD and others.
0 year
Secondary Outcomes (2)
Survival rates of overall cohort and different etiologies
1 year, 3years，10 years
Risk factors of prognosis in overall cohort and different etiologies
10 years
Eligibility Criteria
primary liver cancer
You may qualify if:
- years or older;
- initial diagnosis of primary liver cancer based on enhanced CT or enhanced MRI or pathology
You may not qualify if:
- other types of malignant tumors;
- mental illness, severe cardiopulmonary dysfunction, severe renal insufficiency, serious infection and cerebrovascular accident;
- received liver transplant or other organ transplant.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Nanjing Drum Tower Hospital
Nanjing, Jiangsu, 210008, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal investigator
Study Record Dates
First Submitted
March 15, 2024
First Posted
March 22, 2024
Study Start
January 1, 2010
Primary Completion
August 31, 2024
Study Completion
August 31, 2024
Last Updated
March 27, 2024
Record last verified: 2024-03